Last reviewed · How we verify
advanced renal cell carcinoma
Approved treatments
- Torisel · Pfizer
Temsirolimus is an inhibitor of mTOR, a protein that controls cell division.
Clinical guidelines
- FDA label — any
Temsirolimus injection is indicated for the treatment of advanced renal cell carcinoma. - FDA label — 1L
BAVENCIO in combination with axitinib is indicated for the first-line treatment of patients with advanced renal cell carcinoma (RCC).
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- advanced renal cell carcinoma patent landscape — cliff calendar, originator estates, attackable patents
- advanced renal cell carcinoma treatment landscape brief
- advanced renal cell carcinoma treatment updates RSS
Frequently asked questions about advanced renal cell carcinoma
What drugs treat advanced renal cell carcinoma?
Tracked treatments include Torisel.
What is the treatment for advanced renal cell carcinoma?
Standard treatment for advanced renal cell carcinoma includes Torisel. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for advanced renal cell carcinoma?
FDA label publishes guidelines for advanced renal cell carcinoma. 2 guideline references tracked.
Related
- Treatment landscape: advanced renal cell carcinoma patent cliff · advanced renal cell carcinoma CI report
- Treatment: Torisel · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing